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Abstract
Background: The quaking viable (qk
v) mouse has several developmental defects that result in rapid tremors in the hind
limbs. The qkI gene expresses three major alternatively spliced mRNAs (5, 6 and 7 kb) that encode the QKI-5, QKI-6 and QKI-
7 RNA binding proteins that differ in their C-terminal 30 amino acids. The QKI isoforms are known to regulate RNA
metabolism within oligodendrocytes, however, little is known about their roles during cellular stress.
Methodology/Principal Findings: In this study, we report an interaction between the QKI-6 isoform and a component of
the RNA induced silencing complex (RISC), argonaute 2 (Ago2). We show in glial cells that QKI-6 co-localizes with Ago2 and
the myelin basic protein mRNA in cytoplasmic stress granules.
Conclusions: Our findings define the QKI isoforms as Ago2-interacting proteins. We also identify the QKI-6 isoform as a new
component of stress granules in glial cells.
Citation: Wang Y, Lacroix G, Haines J, Doukhanine E, Almazan G, et al. (2010) The QKI-6 RNA Binding Protein Localizes with the MBP mRNAs in Stress Granules of
Glial Cells. PLoS ONE 5(9): e12824. doi:10.1371/journal.pone.0012824
Editor: Yue Feng, Emory University, United States of America
Received January 3, 2010; Accepted August 12, 2010; Published September 17, 2010
Copyright:  2010 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Multiple Sclerosis Society of Canada (MSSOC) to G.A. and S.R. Y.W. was a recipient of a postdoctoral
fellowship from le Fonds Que ´be ´cois de la recherche sur la Nature et les Technolgies and is supported by a fellowship from the MSSOC. E.V. and G.L. were
recipients of MSSOC studentships. S.R. is a Chercheur National des Fonds en Recherche en Sante ´ du Que ´bec. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: stephane.richard@mcgill.ca
¤ Current address: Public Health Agency of Canada, Ottawa, Ontario, Canada
Introduction
The quaking viable (qk
v) mice represent an animal model with
dysmyelination defects in the central and peripheral nervous
system (CNS, PNS) [1]. Qk
v mice develop normally until about 10
days after birth at which time they display a rapid tremor that is
especially pronounced in the hind limbs with adult mice also
displaying tonic-clonic seizures [1]. The CNS defect is summa-
rized as a lack in maturation of the myelin sheath or the arrest of
myelinogenesis [2]. Oligodendrocyte differentiation is interrupted
in qk
v mice [1].
The genetic defect of the qk
v mice has been linked to the qkI
gene known to express 3 major alternatively spliced mRNAs of 5,
6 and 7 kb [3]. These mRNAs encode QKI-5, QKI-6 and QKI-7
respectively, which differ in their C-terminal 30 amino acids. The
nuclear isoform, QKI-5, harbors a C-terminal nuclear localization
signal (NLS) that is absent in the cytoplasmic isoforms QKI-6 and
QKI-7 [4]. The expression of QKI-5 is highest during
embryogenesis and the expression of cytoplasmic QKI-6 and
QKI-7 isoforms is elevated during myelination. Part of the qk
enhancer/promoter is deleted in the qk
v mice [5] and as a result,
QKI-6 and QKI-7 isoforms are not properly expressed in
oligodendrocytes, as analyzed by immunocytochemistry [6]. It is
thought that the inadequate expression of QKI-6 and QKI-7
causes the lack of oligodendrocyte maturation and the dysmyeli-
nation defects observed in qk
v mice [6]. Consistent with this
hypothesis, the forced expression of QKI-6 and QKI-7 induces
oligodendrocyte and Schwann cell differentiation and maturation
[7,8]. Moreover, a transgenic allele that expresses Flag-QKI-6
specifically in the oligodendroglia lineage, driven by the
proteolipid protein (PLP) promoter rescued the severe tremor
and hypomyelination phenotype, when introduced into the qk
v
mice background [9].
The QKI proteins belong to the heteronuclear ribonucleopro-
tein particle K (hnRNP K) homology (KH) domain family of RNA
binding proteins that bind specific RNA sequences with high
affinity [10,11,12]. The QKI KH domain is embedded in a larger
conserved domain often called the maxi-KH, the GSG (GRP33,
Sam68, GLD-1) or the STAR (Signal Transduction and Activator
of RNA) domain [12,13]. Several post-transcriptional functions
have been attributed to the QKI proteins. The QKI isoforms
regulate the localization and export of myelin basic protein (MBP)
mRNAs [14]. Moreover, the QKI isoforms regulate the stability of
MBP [15] and p27
KIP1 mRNAs [7]. The QKI isoforms have been
proposed to function in alternative splicing in the myelin
associated glycoprotein mRNA [16].
In the present manuscript, we define an interaction between the
QKI isoforms and argonaute 2 (Ago2). Ago2 is a core component
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12824of the RISC complex which regulates gene expression including
mRNA degradation and translation repression [17]. We also show
that QKI-6 co-localizes with Ago2, PABP1, TIA1 and MBP
mRNA in stress granules in glial cells. These findings identify the
QKI-6 isoform as a new component of stress granules in
oligodendrocytes.
Results
The QKI isoforms associate with Ago2
The QKI RNA binding proteins have recently been shown by
photoactivatable-ribonucleoside-enhanced crosslinking and immu-
noprecipitation (PAR-CLIP) to associate with clusters of non-
coding intronic RNAs [18]. Therefore, we reasoned that the QKI
isoforms may associate with components of the RNA-induced
silencing complex (RISC). To examine whether the QKI isoforms
associate with Ago2, a member of the RISC complex, we
performed co-immunoprecipitations in the U343, a human
glioblastoma cell line known to express the three major QKI
isoforms (QKI-5, -6, and -7). Cellular extracts were prepared and
the QKI isoforms were immunopurified using anti-QKI-5, -6 and
-7 antibodies and the bound proteins were separated by SDS-
PAGE followed by immunoblotting with anti-Ago2 antibodies.
Ago-2 was detected by immunoblotting in anti-QKI-5, -6 and -7
antibody immunoprecipitations (Figure 1A). Next we focused on
QKI-6, as it had the highest relative affinity for Ago2. To
determine whether the QKI-6 and Ago2 interaction was RNA-
dependent, U343 cell lysates were pre-incubated with RNase A or
V1, the enzymes that digest ssRNA and dsRNA, respectively,
before performing the immunoprecipitations. The QKI/Ago2
interaction was insensitive to high doses of RNase A or V1
(Figure 1B), suggesting that the interaction is likely mediated by a
protein-protein interaction and not by a bridging RNA.
To identify the regions required for the interaction, QKI-6 and
Ago2 truncated proteins were expressed in HEK293 cells followed
by co-immunoprecipitation assays. The QKI isoforms harbor a
KH domain flanked by the N- (NK) and C- (CK) terminal regions
(Figure 2A), while Ago2 contains an N-terminal region (N-
terminus), as well as PAZ and PIWI domains (Figure 2B). Myc-
Ago2 co-immunoprecipitated with GFP-QKI:1-205, but not with
GFP-QKI:205–325 or GFP-QKI:1–180 (Figure 2A), revealing
that the QKI-6 CK region was required for the interaction with
Ago2. Moreover, GFP-QKI-6 co-immunoprecipitated with myc-
Ago2:392–817, but not myc-Ago2:1–227 or myc-Ago2:1–347
(Figure 2B), indicating that the Ago2 PIWI domain was necessary
and sufficient for interaction with QKI-6.
To investigate whether the QKI isoforms are key accessory
proteins of Ago2 in the RISC complex, we reasoned that reduced
expression of the QKI isoforms would impair the RNA
interference of a luciferase reporter gene. U343 cells were
transfected with siRNAs targeting the QKI isoforms, a negative
control siRNA targeting GFP or a positive control siRNA
targeting Ago2. Twenty-four hours later, the cells were transfected
with a luciferase reporter plasmid along with a control siRNA or a
luciferase siRNA and luciferase activity was assessed 30 h later.
Ago2 knockdown significantly impaired the ability of the luciferase
siRNA to function, whereas the knockdown of the QKI isoforms
had no effect (Figure 3). These results suggest that the QKI
isoforms are not components of the RISC complex and that the
QKI/Ago2 interaction fulfills other functions.
Figure 1. The endogenous QKI isoforms associate with Ago2. (A) U343 cell lysates were subjected to immunoprecipitations (IP) with control
immunoglobulin G (IgG), anti-QKI-5, -QKI-6 and -QKI-7 antibodies. The bound proteins were separated by SDS-PAGE and immunoblotted (IB) with
anti-Ago2 antibodies. (B) U343 cell lysates were treated with 1 mg/ml RNase A, 2 U/100 ml RNase V1 or RNase inhibitor as indicated at 37uC for 1 hr
and subjected to immunoprecipitation with the anti-QKI-6 antibody. The proteins were separated by SDS-PAGE and immunoblotted with anti-Ago-2
antibodies as indicated (upper panel). The activity of the RNases and the RNase inhibitor was verified by agarose gel electrophoresis with 10 mgo f
total RNA (lower panel).
doi:10.1371/journal.pone.0012824.g001
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granules upon oxidative stress treatment
We examined whether QKI-5, QKI-6 and QKI-7 co-localize
with Ago2 in U343 cells. In the absence of any treatment, Ago2
did not co-localize significantly with any of the QKI isoforms
(Figure 4A). Endogenous QKI-5 was exclusively nuclear as
expected (Figure 4A), while QKI-6 and QKI-7 were localized
diffusely throughout the cell with QKI-6 also concentrating in the
nucleus, as detected in U343 cells using anti-QKI-6 antibodies
(Figure 4A). Endogenous Ago2 was localized diffusely in the cell
and accumulated in discrete cytoplasmic foci termed RNA
processing bodies or P bodies (Figure 4A). However, P bodies
were devoid of the QKI isoforms (Figure 4A) and the QKI-7
isoform did not co-localize with DCP1 in P bodies (Figure 5).
Ago2 is known to re-localize to cytoplasmic granules under
stress [19]. Therefore we performed the co-localization studies in
cells treated with 0.5 mM arsenic oxide to induce oxidative stress.
The treatment of U343 cells with arsenic oxide induced Ago2/
QKI-6 and Ago2/QKI-7 co-localization within cytoplasmic
granules in essentially 100% of the cells (Figure 4A, 4B). The
nuclear isoform (QKI-5) did not co-localize with Ago2 demon-
strating isoform specificity (Figure 4A, 4B). We next examined
whether Ago2 and the QKI isoforms co-localized in normal
differentiated primary rat oligodendrocytes. Ago2 co-localized in
.90% of the cells with QKI-6 in cytoplasmic granules in
oligodendrocytes treated with arsenic oxide (Figure 4C, 4D).
Ago2 did not co-localize with the nuclear QKI-5 isoform, as
expected (Figure 4C, 4D). These findings suggest that Ago2
Figure 2. Mapping the domains required for the QKI-6/Ago2 interaction. (A) A schematic illustration of the QKI-6 protein showing its
regions and its amino acid numbering. Expression vectors encoding GFP-QKI-6 and truncation mutants thereof were transfected in HEK293 cells. The
transfected cells were lysed and the cell lysates were subjected to immunoprecipitation with the anti-GFP antibody and the bound proteins
separated by SDS-PAGE. The presence of Ago2 was monitored by using anti-Ago2 antibodies as indicated (left panel). Extracts before
immunoprecipitation were separated by SDS-PAGE and immunoblotted with anti-GFP antibodies to confirm equivalent expression. The molecular
mass markers are shown on the left in kDa. (B) A schematic illustration of Ago2 is shown with its conserved domains and the numbering of its
residues. The GFP-QKI-6 expression plasmid was cotransfected with myc-tagged full-length Ago2 or truncation mutants in HEK293 cells, as indicated.
Twenty four hours after transfection, the cells were lysed and cell lysates were subjected to immunoprecipitation with anti-Myc antibodies followed
by immunoblotting with anti-GFP antibodies. The migration of GFP-QKI-6 is shown (left panel), while the expression of the myc-Ago2 proteins is
shown in the right panel. The asterisks denote non-specific proteins recognized by the anti-myc antibodies. The molecular mass markers are shown
on the left in kDa.
doi:10.1371/journal.pone.0012824.g002
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cells.
QKI-6 and QKI-7 co-localize with PABP1 and TIA1 within
stress granules
To confirm that QKI-6 and QKI-7 are components of stress
granules, we tested under conditions of stress, whether the QKI-6
and QKI-7 isoforms co-localize with the poly A-binding protein
(PABP1), a known marker of stress granules [20]. Indeed, all of the
U343 cells and ,95% of the primary rat oligodendrocytes
exhibited PABP1/QKI-6 and PABP1/QKI-7 co-localization in
stress granules upon arsenic oxide treatment (Figure 6). No
significant co-localization between PABP1 and the QKI isoforms
was observed in the absence of stress (Figure 6). We subsequently
examined whether another marker of stress granules, TIA1, also
co-localized with QKI-6. In ,90% of the primary rat oligoden-
drocytes treated with arsenic oxide, TIA1 co-localized with QKI-
6, but not QKI-5 (Figure 7), demonstrating that the QKI-6
isoform is a component of stress granules in glial cells.
The MBP mRNA, a known QKI target, localizes within
stress granules of primary rat oligodendrocytes
Cellular stress induces rapid shuttling of proteins and RNAs
within stress granules [20]. Their presence within this structure is
reversible, as stress granules are not sites of long-term mRNA
ribonucleoprotein (mRNP) storage [20]. To examine if cellular
stress regulates the ability of certain QKI mRNA targets to localize
within stress granules, in situ hybridization was performed to test
whether MBP mRNA co-localize with the QKI-6 isoform during
stress. The MBP mRNA is a known QKI target with specific
binding sites within its 39-untranslated region [14,15,21,22]. In the
oligodendrocytes, the expression of QKI-6 and QKI-7 facilitates
the mRNA export of MBP mRNAs [14], suggesting that the QKI
RNA binding proteins serve to export certain mRNA targets.
Using primary rat oligodendrocytes, we observed that ,85% of
cells harbor .5 foci that colocalize the MBP mRNA and QKI-6 in
primary rat oligodendrocytes treated with arsenic oxide (Figure 8).
Our results show that QKI-6 and the MBP mRNAs localize in
stress granules in oligodendrocytes.
Discussion
In the present study, we show that the cytoplasmic QKI
isoforms, QKI-6 and QKI-7, but not nuclear isoform (QKI-5),
localize with Ago2, PABP1, and TIA1 within stress granules in the
U343 glioblastoma cell line and in primary rat oligodendrocytes.
Interestingly, the MBP mRNA, a known QKI RNA target
[14,15], also localized in stress granules of primary rat oligoden-
drocytes. These findings identify the QKI-6 isoform as a new
component of stress granules in oligodendrocytes.
In response to environmental stress, mRNAs are transiently
transported to stress granules [23,24]. Interestingly, a component
of the RISC complex, Ago2, also accumulates in stress granules,
but its role is unknown in these structures [19]. It is known that
translational repression occurs in both stress granules and P
bodies, while RNA degradation occurs mainly in P bodies [20].
Our observations that QKI-6 and QKI-7 co-localize with Ago2 in
stress granules, but not in P bodies, suggesting that QKI-6 and
QKI-7 are components of stress granules. In primary rat
oligodendrocytes there is precedence for this with the Staufen
RNA binding protein [25]. We now extend these findings and
show that the QKI-6 isoform is a new component of stress
granules in oligodendrocytes.
The QKI RNA binding proteins are involved in various aspects
of RNA processing including mRNA stability, mRNA export, and
pre-mRNA splicing [1,26]. Ago2 is mainly known for its role as a
component of the RISC complex and its involvement in miRNA-
dependent translational repression [17]. The knockdown of the
QKI isoforms in U343 cells did not affect the RNA interference
function of Ago2 (Figure 3), suggesting that the QKI proteins are
not key components of the RISC complex. Previous reports
showed that fragile X mental retardation 1 (FMR1), an RNA
binding protein, is required for Ago2-mediated translational
regulation [27]. It was shown that the fragile-X-mental-retarda-
Figure 3. RNA interference is not affected by the absence of the
QKI-6 isoform in U343 cells. (A) Control siRNA, siQKI-6 or siAgo2
were transfected in U343 cells and 24 hr later, the pMIR luciferase
plasmid was co-transfected with the renilla luciferase vector and an
siRNA that targets the pgl2 against firefly luciferase or a control siRNA.
Thirty hours later, the cells were lysed and subjected to luciferase assays
or immunoblotting analysis panel B. The firefly luciferase activity was
normalized with renilla luciferase. (B) Cellular extracts from transfected
U343 cells from panel (A) were immunoblotted with anti-Ago2 and anti-
QKI antibodies. Immunoblotting against anti-Sam68 antibodies was
used as a loading control. Absolute quantified levels of protein bands
are presented underneath each blot and were performed using Scion-
Image.
doi:10.1371/journal.pone.0012824.g003
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elements in mRNAs exclusively during activation of translation
under serum starvation [28]. Whether the QKI-6 fulfills a similar
function to FXR1 in conjuction with Ago2 remains to be
investigated.
RNA localization elements are recognized by specific RNA-
binding proteins regulating many aspects of RNA metabolism
[29,30]. The mRNAs of many myelin components, such as MBP,
are translationally repressed and transported to the distal tips of
the oligodendrocyte processes to be locally translated and directly
Figure 4. QKI-6 and QKI-7 isoforms co-localize with Ago2 in cytoplasmic granules in glial cells. (A) U343 cells were untreated or treated
with 0.5 mM arsenic oxide (As2O3) for 45 min. The cells were fixed, permeabilized and immunostained with rabbit anti-QKI-5, -6 and -7 antibodies and
mouse anti-Ago2 antibodies followed by secondary goat anti-rabbit Alexa 488 (green) and goat anti-mouse Alexa 523 (red) antibodies. The nuclei
were counter-stained with DAPI. The scale bar represents 5 mm. (B) The quantification of the co-localization between the QKI isoforms and Ago2
expressed as a percentage is shown. (C) Primary rat oligodendrocytes were untreated or treated with 0.5 mM As2O3 for 45 min and analyzed as in
panel (A). (D) The quantification was performed as in panel (B).
doi:10.1371/journal.pone.0012824.g004
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the nuclear export of MBP mRNAs by associating with a specific
high-affinity QKI response element within the 39-untranslated
region [14,22,33]. These findings identify the QKI-6 isoform as a
new component of stress granules in oligodendrocytes.
Materials and Methods
Cells and transfections
The HEK293 and U343 cell lines were purchased from
American Type Culture Collection (Manassas, VA) and primary
oligodendrocyte precursor cells were prepared as described
previously [34]. To induce oxidative stress, cells were treated with
0.5 mM arsenic trioxide (catalog number A1010, Sigma, St. Louis,
MO) for 45 min as described previously [35]. Plasmids were
transfected with Lipofectamine
TM 2000 (Invitrogen) and siRNAs
were transfected with Lipofectamine
TM RNAiMAX (Invitrogen)
according to the manufacturer’s instructions.
Antibodies and plasmids
Anti-Sam68 and anti-QKI-5, -6 and -7 antibodies were
purchased from Millipore Inc. Antibodies against b-actin and
Flag were purchased from Sigma Inc. The anti-Ago2 antibody was
purchased from Novus Biologicals. The Myc-Ago2 pcDNA was
kindly provided by Gregory J. Hannon (Cold Spring Harbor, NY)
[36]. Myc-Ago2:1–227, myc-Ago2:1–334, and myc-Ago2:392–
817 were generated by PCR with myc-Ago2 as DNA template.
The sequences of the oligonucleotide pairs used were 59-
CACCATGGAGCAAAAGCTCATCTCAG-39 and 59-CTAT-
GCCTTGTA TAAAACGCTGTTG-39 for myc-Ago2:1-227; 59-
CACCATGGAGCAAAAGCTCAT CTC AG-39 and 59-CTA-
CACAATGTTACAGACCTCCAG-39 for myc-Ago2:1-334; and
59-CACCATGGAGCAGAAACTCATCTCTGAAGAGGATC-
TTGT-39 and 59- CTACAGGTGGTACCTGGCCCGGAAG-39
for myc-Ago2:392-817. The amplified PCR fragments were sub-
cloned into the pcDNA
TM3.1 Directional TOPOH Expression
vector (Invitrogen) following the manufacturer’s procedure. The
GFP-QKI:1–180, GFP-QKI:1–205 were described previously
[37]. The GFP-QKI-6:205–325 was generated by using PCR
with GFP-QKI-6 as DNA template [38]. The sequences of
oligonucleotide pairs used were 59- GCATGAATTCACCAGC-
CCTTGCGTTTT C-39 and 59-TACAAATGTGGTATGG-
CTGA-39. The amplified DNA fragment was digested with
EcoRI and BamHI and sub-cloned into the vector pEGFP-C1
(Clontech).
Immunoprecipitation and RNase treatment
U343 cells or transfected HEK 293 cells were harvested and
lysed in Triton X-100 lysis buffer, as described previously [7]. The
extracts were treated with RNaseA (Boehringer Mannheim) at
1 mg/ml for ssRNA digestion or RNaseV1 (Ambion) at 2 U/
100 ml for dsRNA digestion at 37uC for 1 hr. The extracts without
Figure 5. DCP-1 P bodies are devoid of QKI-7. Myc-QKI-7 and Flag-DCP1 were co-transfected in HEK293 cells. Thirty hours later, the cells were
left untreated or treated with 0.5 mM As2O3 for 30 min. The cells were fixed, permeabilized and immunostained with rabbit anti-Myc antibody and
mouse anti-Flag antibody followed by goat anti-rabbit Alexa523 (red) and goat anti-mouse Alexa 488 (green). The nuclei were counter-stained with
DAPI. The scale bar represents 10 mm.
doi:10.1371/journal.pone.0012824.g005
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RNase treatment, the cell lysates were utilized to perform
immunoprecipitations. The bound proteins were analyzed by
immunoblotting with the indicated antibodies.
Immunofluorescence
Cells were grown at 30 to 50% confluency and fixed with 4%
paraformaldehyde in PBS for 30 min and permeabilized with
0.5% Triton X-100 in PBS for 10 min at room temperature. The
permeabilized cells were incubated with primary antibodies in
PBS for 2 hr at RT. The cells were washed 3 times with 0.1%
Triton X-100 in PBS and incubated with the appropriate
fluorescent secondary antibodies (Invitrogen) in PBS for 1 hr
(Millipore Inc. 1:200). Primary antibodies were diluted as follows:
anti-QKIs rabbit polyclonal antibodies (1:200), anti-Ago2 mono-
clonal antibody (Abnova, 1:50), anti-PABP1 rabbit polyclonal
antibody (Cell Signaling, 1:25), anti-PABP1 mouse monoclonal
antibody (Sigma, 1:10), anti-TIA1 goat polyclonal antibody (Santa
Figure 6. QKI-6 and QKI-7 co-localize with PABP1 in stress granules in glial cells. (A) U343 cells were untreated or treated with 0.5 mM
As2O3 for 45 min. The cells were fixed, permeabilized and immunostained with rabbit anti-QKI-5, -6 and -7 antibodies and a mouse anti-PABP1
followed by secondary goat anti-rabbit Alexa523 (red) and goat anti-mouse Alexa 488 (green) antibodies. The nuclei were stained with DAPI. The
scale bar represents 5 mm. (B) The quantification of the co-localization between the QKI isoforms and PABP1 expressed as a percentage is shown.
(C) Primary rat oligodendrocytes were untreated or treated with 0.5 mM As2O3 for 45 min and analyzed as in panel (A). (D) The co-localization was
performed as in panel (B).
doi:10.1371/journal.pone.0012824.g006
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1:100) and anti-Myc monoclonal antibody (Sigma, 1:100).
Fluorescent in situ hybridization (FISH)
A 351 base pair DNA fragment was amplified by PCR using an
expression vector for the MBP 14 kDa isoform [14] with the
following oligonucleotides 59-ATGGCATCACAGAAGAGACC-39
and 59- TCTTCCTCCCCAGCTAAATC-39. The DNA fragment
was cloned into pBluescript KS+ vector. Antisense and sense UTP
digoxigenin (Roche Applied Science) RNA probes were synthesized
with T7 or T3 RNA polymerase in vitro.T h ein situ hybridization was
performed with 5 ng/ml digoxigenin-riboprobe as described [14].
Luciferase assay
U343 cells were transfected with control, Ago2 and QKI siRNAs
using Lipofectamine
TM RNAi Max (Invitrogen). Twenty-four hours
after transfection, the cells were co-transfected with pMIR firefly
luciferase (FL) reporter (Ambion) plasmid and pRL-TK renilla
luciferase (RL) plasmid (Promega) aswell as a control orpgl2 siRNA
targeting the pMIR firefly luciferase. The FL/RL activities were
Figure 7. QKI-6, but not QKI-5 co-localizes with TIA1 in stress granules in primary rat oligodendrocytes. (A) Primary rat
oligodendrocytes were untreated or treated with 0.5 mM As2O3 for 45 min. The cells were fixed, permeabilized and immunostained with rabbit anti-
QKI-5, or -6 antibodies and goat anti-TIA1 antibody followed by secondary donkey anti-rabbit Alexa523 (red) and donkey anti-goat Alexa 488 (green)
antibodies. The nuclei were counter-stained with DAPI. The scale bar represents 5 mm. (B) The quantification of the co-localization between the QKI
isoforms and TIA1 expressed as a percentage is shown.
doi:10.1371/journal.pone.0012824.g007
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LuciferaseH Reporter Assay system (Promega Inc.). In addition, cell
extracts prepared and the proteins were separated on SDS
polyacrylamide gels followed by immunoblotting. All the siRNAs
werepurchasedfrom Dhamacon Inc with targetingsequenceswere:
QKI; GGACUUACAGCCAAACAAC, Ago2; UGGACAUCCC-
CAAAAUUGA and pgl2; CGUACGCGGAAUACUUCGA.
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